Dr Hilary Williams. Consultant in Medical Oncology at Velindre Cancer Centre

Similar documents
Cancer of Unknown Primary (CUP) Protocol

Unknown Primary Service for patients at Chesterfield Royal Hospital

North of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO)

Cancer of Unknown Primary (CUP)

Long-stay patients methodology Published by NHS England and NHS Improvement

Palliative care - the opportunities. Dr David Brooks Macmillan Consultant in Palliative Medicine Chesterfield Royal Hospital

Cancer of Unknown Primary Service

Acute Oncology Services Clinical Forum: Metastatic Spinal Cord Compression. Tuesday 17 th September 2013

What is Acute Oncology? Kay McCallum Acute Oncology Advanced Nurse Practitioner John Radcliffe Hospital Oxford September 2015

COSD & Source of Referral

Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Cancer of Unknown Primary Network Site Specific Group. Clinical Guidelines

Faster Cancer Treatment Indicators: Use cases

CUP Investigation and Management Guidelines V1 West Midlands SCN Acute Oncology, MSCC and CUP ERG /PJJ/

Recognition & Treatment of Malignant Spinal Cord Compression Study Day

Acute Oncology Martin Eatock Consultant Medical Oncologist NICaN Medical Director

Acute Oncology: Service Provision in Smaller Cancer Centres Ernie Marshall Clatterbridge Centre for Oncology

National Standards for Acute Oncology Services

Cancer of Unknown Primary

Overseas Vistiors upfront charging tariff 2017/18. James Paget University Hospitals NHS Foundation Trust

MDT IMPROVEMENT PROJECT. Professor Muntzer Mughal, UCLH

Vacancy list Pathway Boards

Cancer of Unknown Primary (CUP)

Wales Cancer Patient Experience. Survey Aneurin Bevan University Health Board. Published January 2014

Greater Manchester Cancer: Guidelines for Investigation and Management of Malignancy of Unknown Origin (MUO) and Cancer of Unknown Primary (CUP)

Mapping inpatient hospital data across England, Scotland and Wales

MSCC CARE PATHWAYS & CASE STUDIES. By Michael Balloch Spine CNS

Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers

National Prostate Cancer Audit. Bill Cross June 2015

NCIN Conference Feedback 2015

Limitations of the HRG Tariff: The trim point

Referral guide for acute oncology emergencies

Acute Oncology Induction Training Specification

Recommendations for cross-sectional imaging in cancer management, Second edition

Manchester Cancer. Guidelines for Investigation and Management of Malignancy of Unknown Origin (MUO) / Cancer of Unknown Primary (CUP)

Re-audit of Radiotherapy Waiting Times in the United Kingdom, 2007

2015 Detailed Postgraduate Training Report: Grampian

Cancer Outcomes and Services Dataset: Implications for clinical teams

How a fully integrated Acute Oncology Service can benefit the busy medical unit

PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease

Management of thyroid cancer in the Northern and Yorkshire region,

Spinal cord compression

NOSCAN CLINICAL MANAGEMENT GUIDELINE (CMG) AND NOSCAN CHEMOTHERAPY REVIEW (NCR) STATUS DOCUMENT May Status (G / A / R) Status (G / A / R)

David Brooks Macmillan Consultant in Palliative Medicine

MANAGEMENT OF PATIENTS WITH METASTATIC SPINAL CORD COMPRESSION

How an Acute Oncology service can help with managing Cancer of unknown primary

Spinal cord compression: what it means and how it can be treated

Guideline for the Management of Vulval Cancer

Trust Board Meeting in Public: Wednesday 11 July 2018 TB

HOSPITAL MEDICINE BECOMING A PHYSICIAN

Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Cancer of Unknown Primary (CUP) Network Site Specific Group.

Re-audit of Radiotherapy Waiting Times 2005

Palliative Care Emergencies

National Breast Cancer Audit next steps. Martin Lee

Manchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases

Allied Healthcare Professionals Module

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

Ruth Howkins Deputy National Coordinator National Cancer Peer Review

Cancer of Unknown Primary

2013 research report oncology

What do blood cancer patients want? (And what do we need and expect too?)

Staging Issues: Lung Cancer & Mesothelioma. Mick Peake Clinical Lead, NCIN Chair, Lung SSCRG

Delivering 62 Day GP Cancer Waits in a Complex Landscape. Hannah Marder Cancer Manager University Hospitals Bristol

CRN SWP Business Intelligence Unit

An Overview of Health Economics Data and Expertise in Cancer

Prognostic factors in squamous cell anal cancers

Coordination of palliative support networks for the patient and family members: role of oncologist

PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE

SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018

Lessons learnt from establishing an Acute Oncology service. Dr. Pauline Leonard MD FRCP Consultant Medical Oncologist Whittington Health

Further information regarding the Academic F1 programmes commencing August 2017

Cancer Outcomes and Services Dataset. What is COSD? Skin Cancers Workshop October 2012

National Cancer Patient Experience Programme National Survey. Royal National Orthopaedic Hospital NHS Trust. Published September 2014

Integration of palliative care into oncology

National Cancer Peer Review Sarcoma. Julia Hill Acting Deputy National Co-ordinator

Location of cancer services and cancer support services in NEMICS region

Update on Management of Malignant Spinal Cord Compression. Heino Hugel Consultant in Palliative Medicine University Hospital Aintree

Informatics in the new NHS : PHE and NCIN 9 months on. Nicky Coombes National Cancer Intelligence Network

Metastatic Spinal Disease

DEPARTMENT OF ONCOLOGY ELECTIVE

The use of surgery in the elderly. for management of metastatic epidural spinal cord compression

Head and Neck Cancer 2012 COMPARATIVE AUDIT REPORT

2010 National Survey. East Kent Hospitals University NHS Trust

2010 National Survey. The North West London Hospitals NHS Trust

2010 National Survey. Royal National Orthopaedic Hospital NHS Trust

2010 National Survey. The Leeds Teaching Hospitals NHS Trust

CP80 Version: V01. Acute Oncology Management Service Date approved: 8 th May 2015 Date ratified: 1 st June 2015 Review date: 1 st June 2017

2010 National Survey. University College London Hospitals NHS Foundation Trust

LCA Lung Clinical Forum. 21 st October 2014

Medical Training Initiative Post Paediatric Oncology Fellow Retrieval. Job Description Lead Clinician Dr Emma Ross

2010 National Survey. Northern Lincolnshire and Goole Hospitals NHS Foundation Trust

4.1.3 SECONDARY AND TERTIARY HEALTH SERVICES

What to expect following spinal cord injury. Information for patients Therapy Services

Electives Catalogue 2019 Derriford Hospital, Plymouth

CCR Keywords Primary keywords

Early detection and prevention of lymphoedema

Douglas Dorward 5 th Year Medical Student, University of Dundee NCIN Cancer Outcomes Conference, Birmingham 14 th June 2012

UNC GI Clinics UNC GI Procedures

Palliative treatments for lung cancer: What can the oncologist do?

The Cost of Alcohol Frequent Attenders: Staging an Intervention

Transcription:

Dr Hilary Williams. Consultant in Medical Oncology at Velindre Cancer Centre Hilary.williams4@wales.nhs.uk

Thinking about Acute Oncology. Why do we need acute oncology locally? What the Hub VCC provides The Future 1 2 3 4 5-1 -

Where acute oncology began for me ~ (2000) - 2 - Maggie s Centre Kirkcaldy opened 2006

Why do we need acute oncology locally? But doctor if I had been diagnosed earlier would any of this be different? - 3 -

NCIN briefing on colorectal cancer Feb 2012. KEY MESSAGES: Almost 10% of people diagnosed with colorectal cancer die within one month of diagnosis. 56% of people dying within one month are 80 or more years old. 60% of early deaths present initially as emergency cases to hospital. At least 50% of patients who die within one month receive no active treatment. Raising the level of public awareness of colorectal cancer and increasing early diagnosis may help to improve survival rates for colorectal cancer.

The data behind the patient stories 3 Sources ABHB activity figures Outcome of calls to 24 hour chemotherapy patient support line (Viv Cooper) Cancer Unknown Primary data for SE Wales (Dr Paul Shaw) - 5 -

10% of emergency admissions to ABHB have diagnosis of cancer e.g. ~ 6000 pts a year or 17 pts a day. 2010/2011 Admissions Emerg adm, primary diagnosis cancer Emerge adm, All cancer diagnosis Cancer All admissions % 1985 58561 3% 3891 58561 7% Total 10% of emergency pts have active cancer - 6 - Thanks to Sarah Thatcher & Jayne Harding at ABHB

Length of stay by cancer site and admission Cancer site Royal Gwent Nevill Hall Total Avg LoS Total Avg los Lung 194 10.8 125 10.5 Colorectal 143 15.0 98 13.4 Upper GI 133 10.2 61 15.1 Other GI 113 14.0 77 14.5 Haematolo gy 125 15.4 61 9.3 CUP 60 17 108 16 Total 12.5 11.6-7 - Average LoS in ABHB 12.3 days 17% of patients LoS > 22 days

SE Wales Site of CUP Emergency Admissions General surgery Thoracic medicine Gastroenterology Geriatric medicine Endocrinology Gynaecology Cardiology General medicine Trauma and orthopaedics Urology Ear, nose and throat Infectious diseases Clinical haemotology

SE Wales Site of Colorectal Cancer Emergency Admissions General surgery Gastroenterology Geriatric medicine Endocrinology General medicine Thoracic medicine Gynaecology Cardiology Infectious diseases Urology Accident and emergency Clinical haemotology

What happens to patients admitted following call to Chemotherapy pager? Audit of all calls to emergency chemotherapy support pager. April 2010-2011. 941patients were admitted following a call Around 50% admitted outside Cancer Centre (VCC) ~ 200 patients a year admitted to ABHB with acute complication of chemotherapy Length of stay available on 37 patients admitted to RGH Average LoS of 6-7 days, range 1-20 days (Nb- other patients admitted directly & aim for 50% of chemotherapy to be given outside VCC. ). - 10 -

Audit of CUP in SE Wales Cancer Network (Dr Paul Shaw) Reviewed management of CUP patients referred to VCC over 12 months 166 patients identified Median age 68 Patients on average received a total of: 19 investigations for metastatic carcinoma unknown primary, liver 13 investigations for metastatic carcinoma unknown primary, bone In addition Data from PEDW (Patient Episode Data Wales) 944 admissions in 2009 Length of stay (average) 9 days - 11 -

10% of emergency admissions to ABHB have diagnosis of active cancer ~ 6000 pts a year or 17 pts a day with active cancer Acute care takes 25% of NHS cancer spend 10-15% of all acute beds used for cancer care Can we afford not to invest in AOS? - 12 - Anecdotally patient experience variable

So how do we do it? Hub and spoke model - 13 -

What is VCC providing & how is this developing? - 14 -

Acute Complications of Cancer - What the Medical Team Needs To Know Hilary Williams Consultant Oncology at Velindre Cancer Centre

Thinking about shape acute oncology in AB Health Board. Patient focused care Appropriate rapid decision making Benefit- Patient Direct Clinical Role Support management complications of treatment Rapid focused pathway cancer unknown primary Predict 5 patients admitted every 24 hours to ABH with known or likely cancer Benefit- cost Reduced length stay Reduced investigations Reduced admissions Mon-Fri Service at RGH & NHH Link with Visiting Consultants Costs Admin Office & Clinic space IT 2 Specialist nurse per hospital Rapid liaison VCC & rapid access clinics Engage Palliative care Radiology Current pathways Education Admitting & A & E teams Protocols e. g. Unknown primary Spinal Cord Compression Education junior doctor teams - - Developmental Role

In more detail Key roles of CNS Review all admissions acute complications chemotherapy New presentation metatastic disease MSCC co-ordinator Education Challenges Establish key links with Chemo day unit Local palliative care VCC hub Link visiting consultants Link with established service s Link with community Establishing outcomes s Out of hours service - 17 - Engagement Management Review CONFIDENTIAL

South East Wales Cancer Network CUP Pathway ( Pall care/oncology Review need for investigations/biopsy Refer to site specific cancer MDT Yes Patient with suspected Metastatic Malignancy of undefined Primary on imaging or pathology PS3/4 or Unsuitable for cancer specific Rx? No Liase with site specific oncologist to consider special diagnostic tests (B) & biopsy Yes Likely primary tumour identified? Uncertain Patient with specific CUP syndromes No Patient with confirmed CUP Refer Non-epithelialmalignancies to site specific MDT/oncologist Lymphoma Haematology team Melanoma Dr Kumar Sarcoma Dr Tilsley Tel AEB sec and patient allocated next available Oncology OPC with appropriate consultant Squamous carcinoma involving upper/mid head and neck nodes Adenocarcinoma involving axillary nodes Squamous carcinoma involving inguinal nodes Solitarymetastasis (brain, bone, skin, lung, liver) Radical treatment possibility Dr M Evans/ Dr N Paniapan Sec Head and Neck Poorly differentiated carcinoma with a midline nodal distribution Dr M Button/ Dr J Lester Sec Urology Dr S Waters/ Dr H Passant Sec (Daphe) Breast Female with predominant peritoneal adenocarcinoma Dr E Hudson/ Dr R Jones Sec (Name) Gynaecology Dr E Hudson/ Dr R Jones Sec (Name) Gynaecology Poorly differentiated neuroendocrine tumour Dr H Williams Sec Gastrointestinal Dr O Tilsley (BRAIN/BONE) Sec Dr A Brewster (LUNG) or Lung MDT/Lung physcians Sec Dr H Williams (LIVER) or HPB MDT Sec Dr S Kumar (SKIN) & skin MDT Sec

With acute oncology service in place future opportunities Earlier cancer diagnosis metastati c disease & improved one year survivals - 19 - And measure it all

And if you don t remember anything else 10% of emergency admissions to ABHB have diagnosis of active cancer ~ 6000 pts a year or 17 pts a day with active cancer Acute care takes 25% of NHS cancer spend 10-15% of all acute beds used for cancer care Can we afford not to invest in AOS? - 20 - Anecdotally patient experience variable